Department of Health and Human Services April 30, 2009 – Federal Register Recent Federal Regulation Documents

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA revises the minimum age of treatment from 6 weeks to 8 weeks for kittens treated with a topical selamectin solution.

The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Cochineal Extract and Carmine: Declaration by Name on the Label of All Foods and Cosmetic Products That Contain These Color AdditivesSmall Entity Compliance Guide.'' The small entity compliance guide (SECG) is being issued for a final rule published in the Federal Register of January 5, 2009, and it is intended to set forth in plain language the requirements of the regulation and to help small businesses understand the regulation.